Clinical Trials Directory

Trials / Unknown

UnknownNCT01943448

Macular Hemorrhage in Myopic Eyes

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Visual impairment in high myopic eyes is mainly due to the different types of myopic maculopathies, such as diffuse or patchy atrophy, lacquer cracks and choroidal neovascularization. Macular hemorrhage was one of those complications. Despite choroidal neovascularization, simple hemorrhage from rupture of Bruch's membrane and choroidal microcirculation is also the cause of hemorrhage. The prognosis of those eyes with simple hemorrhage is generally good. However, some patients had persistently poor vision after the absorption of the hemorrhage. In the literature, the visual prognosis in those patients was reported to be associated with the microstructure change under the optical coherent tomography (OCT) or the presentation of the autofluorescence. The investigators will collect the patients with high myopia and presenting with macular hemorrhage. High resolution OCT and autofluorescence imaging will be used to analyze the change of the microstructure of retina and its correlation with the visual prognosis.

Conditions

Timeline

Start date
2013-08-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2013-09-17
Last updated
2014-04-15

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01943448. Inclusion in this directory is not an endorsement.